Search research articles
Contact Us
Filters
Showing results (191-200 of 223) with videos related to
Page
of 23
Sort By:
International Journal of Molecular Sciences
|
March 28, 2024
<i>Anaerobutyricum soehngenii</i> Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice
Anne Linde Mak, Quinten J J Augustijn, Clément J F Heymann, et al.
The Lancet. Haematology
|
June 12, 2022
Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial
Nick A de Jonge, Jonne J Sikkens, Sonja Zweegman, et al.
International Journal of Cancer
|
May 4, 2024
The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer
Sophie H A E Derks, Edgar L van der Meer, Arjen Joosse, et al.
Molecular Oncology
|
May 25, 2024
Comprehensive characterization of circulating tumor cells and cell-free DNA in patients with metastatic melanoma
Manouk K Bos, Jaco Kraan, Martijn P A Starmans, et al.
Investigational New Drugs
|
April 25, 2022
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
Patricia LoRusso, Mark J Ratain, Toshihiko Doi, et al.
Psycho-Oncology
|
April 30, 2025
Improving Shared Decision-Making in Early Phase Clinical Trials and Palliative Care: A Prospective Study on the Impact of an Online Value Clarification Tool Intervention
Liza G G van Lent, Julia C M van Weert, Maja J A de Jonge, et al.
BMC Palliative Care
|
December 1, 2019
Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT)
Liza G G van Lent, Nicole K Stoel, Julia C M van Weert, et al.
British Journal of Cancer
|
April 15, 2004
Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor
A Sparreboom, D F S Kehrer, R H J Mathijssen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2005
Phase I pharmacokinetic, food effect, and pharmacogenetic study of oral irinotecan given as semisolid matrix capsules in patients with solid tumors
Otto Soepenberg, Herlinde Dumez, Jaap Verweij, et al.
Hepatology (Baltimore, Md.)
|
July 16, 2024
An integrated analysis of bile acid metabolism in humans with severe obesity
Ömrüm Aydin, Annika Wahlström, Patrick A de Jonge, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 223) with videos related to
Sort By:
Page
of 23
International Journal of Molecular Sciences
|
March 28, 2024
<i>Anaerobutyricum soehngenii</i> Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice
Anne Linde Mak, Quinten J J Augustijn, Clément J F Heymann, et al.
The Lancet. Haematology
|
June 12, 2022
Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial
Nick A de Jonge, Jonne J Sikkens, Sonja Zweegman, et al.
International Journal of Cancer
|
May 4, 2024
The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer
Sophie H A E Derks, Edgar L van der Meer, Arjen Joosse, et al.
Molecular Oncology
|
May 25, 2024
Comprehensive characterization of circulating tumor cells and cell-free DNA in patients with metastatic melanoma
Manouk K Bos, Jaco Kraan, Martijn P A Starmans, et al.
Investigational New Drugs
|
April 25, 2022
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
Patricia LoRusso, Mark J Ratain, Toshihiko Doi, et al.
Psycho-Oncology
|
April 30, 2025
Improving Shared Decision-Making in Early Phase Clinical Trials and Palliative Care: A Prospective Study on the Impact of an Online Value Clarification Tool Intervention
Liza G G van Lent, Julia C M van Weert, Maja J A de Jonge, et al.
BMC Palliative Care
|
December 1, 2019
Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT)
Liza G G van Lent, Nicole K Stoel, Julia C M van Weert, et al.
British Journal of Cancer
|
April 15, 2004
Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor
A Sparreboom, D F S Kehrer, R H J Mathijssen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2005
Phase I pharmacokinetic, food effect, and pharmacogenetic study of oral irinotecan given as semisolid matrix capsules in patients with solid tumors
Otto Soepenberg, Herlinde Dumez, Jaap Verweij, et al.
Hepatology (Baltimore, Md.)
|
July 16, 2024
An integrated analysis of bile acid metabolism in humans with severe obesity
Ömrüm Aydin, Annika Wahlström, Patrick A de Jonge, et al.
Page
of 23